GGHC
Gilder Gagnon Howe & Co’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,394
| Closed | -$474K | – | 271 |
|
|
2024
Q2 | $474K | Sell |
24,394
-479,780
| -95% | -$9.33M | 0.01% | 234 |
|
|
2024
Q1 | $18.9M | Buy |
504,174
+1,703
| +0.3% | +$63.9K | 0.24% | 89 |
|
|
2023
Q4 | $28.1M | Buy |
502,471
+3,350
| +0.7% | +$187K | 0.39% | 65 |
|
|
2023
Q3 | $20.6M | Buy |
499,121
+473,845
| +1,875% | +$19.5M | 0.31% | 74 |
|
|
2023
Q2 | $1.41M | Buy |
25,276
+9,566
| +61% | +$534K | 0.02% | 216 |
|
|
2023
Q1 | $876K | Buy |
15,710
+5,588
| +55% | +$312K | 0.01% | 200 |
|
|
2022
Q4 | $369K | Sell |
10,122
-14,580
| -59% | -$531K | 0.01% | 224 |
|
|
2022
Q3 | $704K | Sell |
24,702
-542,785
| -96% | -$15.5M | 0.01% | 209 |
|
|
2022
Q2 | $25.7M | Sell |
567,487
-176,294
| -24% | -$7.98M | 0.46% | 61 |
|
|
2022
Q1 | $56.6M | Sell |
743,781
-22,647
| -3% | -$1.72M | 0.52% | 57 |
|
|
2021
Q4 | $114M | Sell |
766,428
-11,319
| -1% | -$1.69M | 0.65% | 49 |
|
|
2021
Q3 | $113M | Buy |
777,747
+922
| +0.1% | +$134K | 0.59% | 55 |
|
|
2021
Q2 | $152M | Sell |
776,825
-4,810
| -0.6% | -$942K | 0.75% | 41 |
|
|
2021
Q1 | $141M | Sell |
781,635
-15,020
| -2% | -$2.72M | 0.76% | 38 |
|
|
2020
Q4 | $113M | Buy |
796,655
+108,044
| +16% | +$15.3M | 0.56% | 57 |
|
|
2020
Q3 | $85.9M | Buy |
688,611
+169,443
| +33% | +$21.1M | 0.53% | 64 |
|
|
2020
Q2 | $46.4M | Buy |
+519,168
| New | +$46.4M | 0.36% | 82 |
|